$PCRX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Pacira BioSciences, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Pacira BioSciences, Inc.. Get notifications about new insider transactions in Pacira BioSciences, Inc. for free.
Page: < prev 1 2 3 4 5 6 ... 9 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 01 2020 | PCRX | Pacira BioSciences ... | LARANJEIRA CHARLES ANTHONY | SVP, Technical Oper ... | Sell | S | 51.77 | 6,859 | 355,090 | 22,028 | 28.9 K to 22 K (-23.74 %) |
Jul 01 2020 | PCRX | Pacira BioSciences ... | LARANJEIRA CHARLES ANTHONY | SVP, Technical Oper ... | Sell | S | 50.01 | 51,464 | 2,573,715 | 28,887 | 80.4 K to 28.9 K (-64.05 %) |
Jul 01 2020 | PCRX | Pacira BioSciences ... | LARANJEIRA CHARLES ANTHONY | SVP, Technical Oper ... | Buy | M | 44.10 | 30,000 | 1,323,000 | 80,351 | 50.4 K to 80.4 K (+59.58 %) |
Jul 01 2020 | PCRX | Pacira BioSciences ... | LARANJEIRA CHARLES ANTHONY | SVP, Technical Oper ... | Buy | M | 43.54 | 7,500 | 326,550 | 50,351 | 42.9 K to 50.4 K (+17.50 %) |
Jul 01 2020 | PCRX | Pacira BioSciences ... | LARANJEIRA CHARLES ANTHONY | SVP, Technical Oper ... | Buy | M | 38.35 | 15,000 | 575,250 | 42,851 | 27.9 K to 42.9 K (+53.86 %) |
Jul 01 2020 | PCRX | Pacira BioSciences ... | LARANJEIRA CHARLES ANTHONY | SVP, Technical Oper ... | Buy | M | 37.81 | 3,750 | 141,788 | 27,851 | 24.1 K to 27.9 K (+15.56 %) |
Jun 11 2020 | PCRX | Pacira BioSciences ... | WINSTON ROY | Chief Clinical Offi ... | Option Exercise | A | 47.65 | 35,000 | 1,667,750 | 35,000 | |
Jun 11 2020 | PCRX | Pacira BioSciences ... | WINSTON ROY | Chief Clinical Offi ... | Grant | A | 0.00 | 14,000 | 0 | 39,237 | 25.2 K to 39.2 K (+55.47 %) |
Jun 11 2020 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Option Exercise | A | 47.65 | 35,000 | 1,667,750 | 35,000 | |
Jun 11 2020 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Grant | A | 0.00 | 14,000 | 0 | 24,887 | 10.9 K to 24.9 K (+128.59 %) |
Jun 11 2020 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Option Exercise | A | 47.65 | 275,000 | 13,103,750 | 275,000 | |
Jun 11 2020 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Grant | A | 0.00 | 33,300 | 0 | 200,209 | 166.9 K to 200.2 K (+19.95 %) |
Jun 11 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Option Exercise | A | 47.65 | 12,000 | 571,800 | 12,000 | |
Jun 11 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Grant | A | 0.00 | 4,800 | 0 | 12,633 | 7.8 K to 12.6 K (+61.28 %) |
Jun 11 2020 | PCRX | Pacira BioSciences ... | Reinhart Charles A. III | Chief Financial Off ... | Option Exercise | A | 47.65 | 31,500 | 1,500,975 | 31,500 | |
Jun 11 2020 | PCRX | Pacira BioSciences ... | Reinhart Charles A. III | Chief Financial Off ... | Grant | A | 0.00 | 12,600 | 0 | 27,447 | 14.8 K to 27.4 K (+84.87 %) |
Jun 11 2020 | PCRX | Pacira BioSciences ... | REINHARDT MAX | President | Option Exercise | A | 47.65 | 35,000 | 1,667,750 | 35,000 | |
Jun 11 2020 | PCRX | Pacira BioSciences ... | REINHARDT MAX | President | Grant | A | 0.00 | 14,000 | 0 | 14,000 | 0 to 14 K |
Jun 11 2020 | PCRX | Pacira BioSciences ... | McLoughlin Dennis | Chief Commercial Of ... | Option Exercise | A | 47.65 | 35,000 | 1,667,750 | 35,000 | |
Jun 11 2020 | PCRX | Pacira BioSciences ... | McLoughlin Dennis | Chief Commercial Of ... | Grant | A | 0.00 | 14,000 | 0 | 28,898 | 14.9 K to 28.9 K (+93.97 %) |
Jun 11 2020 | PCRX | Pacira BioSciences ... | LARANJEIRA CHARLES ANTHONY | SVP, Technical Oper ... | Option Exercise | A | 47.65 | 35,000 | 1,667,750 | 35,000 | |
Jun 11 2020 | PCRX | Pacira BioSciences ... | LARANJEIRA CHARLES ANTHONY | SVP, Technical Oper ... | Grant | A | 0.00 | 14,000 | 0 | 24,101 | 10.1 K to 24.1 K (+138.60 %) |
Jun 11 2020 | PCRX | Pacira BioSciences ... | PACE GARY W | Director | Option Exercise | A | 47.65 | 8,027 | 382,487 | 8,027 | |
Jun 11 2020 | PCRX | Pacira BioSciences ... | PACE GARY W | Director | Grant | A | 0.00 | 1,260 | 0 | 59,949 | 58.7 K to 59.9 K (+2.15 %) |
Jun 11 2020 | PCRX | Pacira BioSciences ... | LONGENECKER JOHN P PHD | Director | Option Exercise | A | 47.65 | 8,027 | 382,487 | 8,027 | |
Jun 11 2020 | PCRX | Pacira BioSciences ... | LONGENECKER JOHN P PHD | Director | Grant | A | 0.00 | 1,260 | 0 | 17,757 | 16.5 K to 17.8 K (+7.64 %) |
Jun 11 2020 | PCRX | Pacira BioSciences ... | Kronenfeld Mark A. | Director | Option Exercise | A | 47.65 | 8,027 | 382,487 | 8,027 | |
Jun 11 2020 | PCRX | Pacira BioSciences ... | Kronenfeld Mark A. | Director | Grant | A | 0.00 | 1,260 | 0 | 15,671 | 14.4 K to 15.7 K (+8.74 %) |
Jun 11 2020 | PCRX | Pacira BioSciences ... | HASTINGS PAUL J | Director | Option Exercise | A | 47.65 | 8,027 | 382,487 | 8,027 | |
Jun 11 2020 | PCRX | Pacira BioSciences ... | HASTINGS PAUL J | Director | Grant | A | 0.00 | 1,260 | 0 | 6,116 | 4.9 K to 6.1 K (+25.95 %) |
Jun 11 2020 | PCRX | Pacira BioSciences ... | Greenstreet Yvonne | Director | Option Exercise | A | 47.65 | 8,027 | 382,487 | 8,027 | |
Jun 11 2020 | PCRX | Pacira BioSciences ... | Greenstreet Yvonne | Director | Grant | A | 0.00 | 1,260 | 0 | 11,021 | 9.8 K to 11 K (+12.91 %) |
Jun 11 2020 | PCRX | Pacira BioSciences ... | Froimson Mark | Director | Option Exercise | A | 47.65 | 8,027 | 382,487 | 8,027 | |
Jun 11 2020 | PCRX | Pacira BioSciences ... | Froimson Mark | Director | Grant | A | 0.00 | 1,260 | 0 | 5,976 | 4.7 K to 6 K (+26.72 %) |
Jun 11 2020 | PCRX | Pacira BioSciences ... | CHRISTIE CHRISTOPHER | Director | Option Exercise | A | 47.65 | 8,027 | 382,487 | 8,027 | |
Jun 11 2020 | PCRX | Pacira BioSciences ... | CHRISTIE CHRISTOPHER | Director | Grant | A | 0.00 | 1,260 | 0 | 1,260 | 0 to 1.3 K |
Jun 11 2020 | PCRX | Pacira BioSciences ... | Brege Laura | Director | Option Exercise | A | 47.65 | 8,027 | 382,487 | 8,027 | |
Jun 11 2020 | PCRX | Pacira BioSciences ... | Brege Laura | Director | Grant | A | 0.00 | 1,260 | 0 | 7,921 | 6.7 K to 7.9 K (+18.92 %) |
Jun 08 2020 | PCRX | Pacira BioSciences ... | McLoughlin Dennis | Chief Commercial Of ... | Sell | S | 46.33 | 1,447 | 67,041 | 14,898 | 16.3 K to 14.9 K (-8.85 %) |
Jun 08 2020 | PCRX | Pacira BioSciences ... | LARANJEIRA CHARLES ANTHONY | SVP, Technical Oper ... | Sell | S | 46.33 | 863 | 39,984 | 10,101 | 11 K to 10.1 K (-7.87 %) |
Jun 08 2020 | PCRX | Pacira BioSciences ... | HASTINGS PAUL J | Director | Sell | S | 47.46 | 2,025 | 96,107 | 4,856 | 6.9 K to 4.9 K (-29.43 %) |
Jun 08 2020 | PCRX | Pacira BioSciences ... | Brege Laura | Director | Sell | S | 48.70 | 2,100 | 102,270 | 6,661 | 8.8 K to 6.7 K (-23.97 %) |
Jun 08 2020 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Sell | S | 48.61 | 5,904 | 286,993 | 10,887 | 16.8 K to 10.9 K (-35.16 %) |
Jun 08 2020 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Sell | S | 46.33 | 2,402 | 111,287 | 16,791 | 19.2 K to 16.8 K (-12.51 %) |
Jun 08 2020 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Sell | S | 48.49 | 1,721 | 83,451 | 166,909 | 168.6 K to 166.9 K (-1.02 %) |
Jun 08 2020 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Sell | S | 48.08 | 15,390 | 739,951 | 168,630 | 184 K to 168.6 K (-8.36 %) |
Jun 08 2020 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Sell | S | 46.33 | 14,314 | 663,182 | 184,020 | 198.3 K to 184 K (-7.22 %) |
Jun 08 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 48.37 | 1,752 | 84,744 | 7,833 | 9.6 K to 7.8 K (-18.28 %) |
Jun 08 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 46.33 | 879 | 40,725 | 9,585 | 10.5 K to 9.6 K (-8.40 %) |
Jun 08 2020 | PCRX | Pacira BioSciences ... | Reinhart Charles A. III | Chief Financial Off ... | Sell | S | 46.33 | 1,489 | 68,987 | 14,847 | 16.3 K to 14.8 K (-9.11 %) |
Jun 04 2020 | PCRX | Pacira BioSciences ... | Manning Donald C. | Chief Medical Offic ... | Option Exercise | A | 43.58 | 71,300 | 3,107,254 | 71,300 | |
Jun 04 2020 | PCRX | Pacira BioSciences ... | Manning Donald C. | Chief Medical Offic ... | Grant | A | 0.00 | 28,500 | 0 | 28,500 | 0 to 28.5 K |
May 21 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Option Exercise | M | 10.34 | 2,000 | 20,680 | 14,180 | |
May 21 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Option Exercise | M | 10.34 | 2,000 | 20,680 | 16,180 | |
May 21 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 45.26 | 2,000 | 90,520 | 10,464 | 12.5 K to 10.5 K (-16.05 %) |
May 21 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Buy | M | 10.34 | 2,000 | 20,680 | 12,464 | 10.5 K to 12.5 K (+19.11 %) |
May 21 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 42.81 | 2,000 | 85,620 | 10,464 | 12.5 K to 10.5 K (-16.05 %) |
May 21 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Buy | M | 10.34 | 2,000 | 20,680 | 12,464 | 10.5 K to 12.5 K (+19.11 %) |
Mar 16 2020 | PCRX | Pacira BioSciences ... | PACE GARY W | Director | Option Exercise | M | 13.98 | 5,000 | 69,900 | 0 | |
Mar 16 2020 | PCRX | Pacira BioSciences ... | PACE GARY W | Director | Option Exercise | M | 1.61 | 7,438 | 11,975 | 0 | |
Mar 16 2020 | PCRX | Pacira BioSciences ... | PACE GARY W | Director | Option Exercise | M | 1.61 | 4,649 | 7,485 | 0 | |
Mar 16 2020 | PCRX | Pacira BioSciences ... | PACE GARY W | Director | Option Exercise | M | 1.61 | 4,649 | 7,485 | 0 | |
Mar 16 2020 | PCRX | Pacira BioSciences ... | PACE GARY W | Director | Buy | M | 13.98 | 5,000 | 69,900 | 58,689 | 53.7 K to 58.7 K (+9.31 %) |
Mar 16 2020 | PCRX | Pacira BioSciences ... | PACE GARY W | Director | Buy | M | 1.61 | 7,438 | 11,975 | 53,689 | 46.3 K to 53.7 K (+16.08 %) |
Mar 16 2020 | PCRX | Pacira BioSciences ... | PACE GARY W | Director | Buy | M | 1.61 | 4,649 | 7,485 | 46,251 | 41.6 K to 46.3 K (+11.17 %) |
Mar 16 2020 | PCRX | Pacira BioSciences ... | PACE GARY W | Director | Buy | M | 1.61 | 4,649 | 7,485 | 41,602 | 37 K to 41.6 K (+12.58 %) |
Mar 16 2020 | PCRX | Pacira BioSciences ... | LONGENECKER JOHN P PHD | Director | Option Exercise | M | 1.61 | 3,736 | 6,015 | 0 | |
Mar 16 2020 | PCRX | Pacira BioSciences ... | LONGENECKER JOHN P PHD | Director | Buy | M | 1.61 | 3,736 | 6,015 | 16,497 | 12.8 K to 16.5 K (+29.28 %) |
Mar 16 2020 | PCRX | Pacira BioSciences ... | LONGENECKER JOHN P PHD | Director | Option Exercise | M | 1.61 | 3,736 | 6,015 | 0 | |
Mar 16 2020 | PCRX | Pacira BioSciences ... | LONGENECKER JOHN P PHD | Director | Buy | M | 1.61 | 3,736 | 6,015 | 16,497 | 12.8 K to 16.5 K (+29.28 %) |
Mar 12 2020 | PCRX | Pacira BioSciences ... | WINSTON ROY | Chief Clinical Offi ... | Buy | P | 36.50 | 2,500 | 91,250 | 25,237 | 22.7 K to 25.2 K (+11.00 %) |
Feb 12 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Option Exercise | M | 10.81 | 3,000 | 32,430 | 23,820 | |
Feb 12 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 49.81 | 1,000 | 49,810 | 10,464 | 11.5 K to 10.5 K (-8.72 %) |
Feb 12 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 48.81 | 1,000 | 48,810 | 11,464 | 12.5 K to 11.5 K (-8.02 %) |
Feb 12 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 47.81 | 1,000 | 47,810 | 12,464 | 13.5 K to 12.5 K (-7.43 %) |
Feb 12 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Option Exercise | M | 10.81 | 3,000 | 32,430 | 23,820 | |
Feb 12 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Buy | M | 10.81 | 3,000 | 32,430 | 13,464 | 10.5 K to 13.5 K (+28.67 %) |
Feb 12 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 49.81 | 1,000 | 49,810 | 10,464 | 11.5 K to 10.5 K (-8.72 %) |
Feb 12 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 48.81 | 1,000 | 48,810 | 11,464 | 12.5 K to 11.5 K (-8.02 %) |
Feb 12 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 47.81 | 1,000 | 47,810 | 12,464 | 13.5 K to 12.5 K (-7.43 %) |
Feb 12 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Buy | M | 10.81 | 3,000 | 32,430 | 13,464 | 10.5 K to 13.5 K (+28.67 %) |
Feb 10 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Option Exercise | M | 10.81 | 170 | 1,838 | 26,820 | |
Feb 10 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Option Exercise | M | 10.81 | 830 | 8,972 | 26,990 | |
Feb 10 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 46.81 | 170 | 7,958 | 10,464 | 10.6 K to 10.5 K (-1.60 %) |
Feb 10 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Buy | M | 10.81 | 170 | 1,838 | 10,634 | 10.5 K to 10.6 K (+1.62 %) |
Feb 10 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 46.81 | 830 | 38,852 | 10,464 | 11.3 K to 10.5 K (-7.35 %) |
Feb 10 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Buy | M | 10.81 | 830 | 8,972 | 11,294 | 10.5 K to 11.3 K (+7.93 %) |
Jan 17 2020 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Option Exercise | M | 10.81 | 25,000 | 270,250 | 243,129 | |
Jan 17 2020 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Sell | S | 43.48 | 1,975 | 85,873 | 1,208 | 3.2 K to 1.2 K (-62.05 %) |
Jan 17 2020 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Sell | S | 42.61 | 23,025 | 981,095 | 3,183 | 26.2 K to 3.2 K (-87.85 %) |
Jan 17 2020 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Buy | M | 10.81 | 25,000 | 270,250 | 26,208 | 1.2 K to 26.2 K (+2,069.54 %) |
Dec 30 2019 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Option Exercise | M | 5.49 | 10,000 | 54,900 | 16,356 | |
Dec 30 2019 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Option Exercise | M | 1.61 | 10,000 | 16,100 | 19,500 | |
Dec 30 2019 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Buy | M | 5.49 | 10,000 | 54,900 | 162,299 | 152.3 K to 162.3 K (+6.57 %) |
Dec 30 2019 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Buy | M | 1.61 | 10,000 | 16,100 | 152,299 | 142.3 K to 152.3 K (+7.03 %) |
Dec 26 2019 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Option Exercise | M | 10.81 | 1,000 | 10,810 | 27,820 | |
Dec 26 2019 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 45.92 | 1,000 | 45,920 | 10,464 | 11.5 K to 10.5 K (-8.72 %) |
Dec 26 2019 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Buy | M | 10.81 | 1,000 | 10,810 | 11,464 | 10.5 K to 11.5 K (+9.56 %) |
Dec 19 2019 | PCRX | Pacira BioSciences ... | Froimson Mark | Director | Gift | G | 0.00 | 300 | 0 | 4,716 | 5 K to 4.7 K (-5.98 %) |
Dec 18 2019 | PCRX | Pacira BioSciences ... | McLoughlin Dennis | Chief Commercial Of ... | Sell | S | 45.79 | 3,671 | 168,108 | 16,116 | 19.8 K to 16.1 K (-18.55 %) |
Dec 04 2019 | PCRX | Pacira BioSciences ... | LONGENECKER JOHN P PHD | Director | Option Exercise | M | 1.61 | 3,128 | 5,036 | 3,736 | |
Dec 04 2019 | PCRX | Pacira BioSciences ... | LONGENECKER JOHN P PHD | Director | Option Exercise | M | 1.61 | 872 | 1,404 | 0 | |
Dec 04 2019 | PCRX | Pacira BioSciences ... | LONGENECKER JOHN P PHD | Director | Sell | S | 46.13 | 1,300 | 59,972 | 12,761 | 14.1 K to 12.8 K (-9.25 %) |
Dec 04 2019 | PCRX | Pacira BioSciences ... | LONGENECKER JOHN P PHD | Director | Buy | M | 1.61 | 3,128 | 5,036 | 14,061 | 10.9 K to 14.1 K (+28.61 %) |
Dec 04 2019 | PCRX | Pacira BioSciences ... | LONGENECKER JOHN P PHD | Director | Buy | M | 1.61 | 872 | 1,404 | 10,933 | 10.1 K to 10.9 K (+8.67 %) |
Dec 04 2019 | PCRX | Pacira BioSciences ... | LONGENECKER JOHN P PHD | Director | Option Exercise | M | 1.61 | 3,128 | 5,036 | 3,736 | |
Dec 04 2019 | PCRX | Pacira BioSciences ... | LONGENECKER JOHN P PHD | Director | Option Exercise | M | 1.61 | 872 | 1,404 | 0 | |
Dec 04 2019 | PCRX | Pacira BioSciences ... | LONGENECKER JOHN P PHD | Director | Sell | S | 46.13 | 1,300 | 59,972 | 12,761 | 14.1 K to 12.8 K (-9.25 %) |
Dec 04 2019 | PCRX | Pacira BioSciences ... | LONGENECKER JOHN P PHD | Director | Buy | M | 1.61 | 3,128 | 5,036 | 14,061 | 10.9 K to 14.1 K (+28.61 %) |
Dec 04 2019 | PCRX | Pacira BioSciences ... | LONGENECKER JOHN P PHD | Director | Buy | M | 1.61 | 872 | 1,404 | 10,933 | 10.1 K to 10.9 K (+8.67 %) |
Nov 19 2019 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Option Exercise | M | 10.81 | 25,000 | 270,250 | 288,670 | |
Nov 19 2019 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Sell | S | 42.81 | 25,000 | 1,070,250 | 1,208 | 26.2 K to 1.2 K (-95.39 %) |
Nov 19 2019 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Buy | M | 10.81 | 25,000 | 270,250 | 26,208 | 1.2 K to 26.2 K (+2,069.54 %) |
Nov 19 2019 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Sell | S | 42.81 | 45,000 | 1,926,450 | 142,299 | 187.3 K to 142.3 K (-24.03 %) |
Nov 13 2019 | PCRX | Pacira BioSciences ... | Ellis Ronald J. Jr. | Director | Option Exercise | C | 0.00 | 14,329,052 | 0 | 0 | |
Nov 13 2019 | PCRX | Pacira BioSciences ... | Ellis Ronald J. Jr. | Director | Buy | C | 0.00 | 580,357 | 0 | 774,056 | 193.7 K to 774.1 K (+299.62 %) |
Nov 13 2019 | PCRX | Pacira BioSciences ... | Ellis Ronald J. Jr. | Director | Option Exercise | C | 0.00 | 14,329,052 | 0 | 0 | |
Nov 13 2019 | PCRX | Pacira BioSciences ... | Ellis Ronald J. Jr. | Director | Buy | C | 0.00 | 580,357 | 0 | 774,056 | 193.7 K to 774.1 K (+299.62 %) |
Nov 12 2019 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Option Exercise | M | 10.81 | 180 | 1,946 | 29,820 | |
Nov 12 2019 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Option Exercise | M | 10.34 | 4,820 | 49,839 | 18,180 | |
Nov 12 2019 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 43.59 | 5,000 | 217,950 | 10,640 | 15.6 K to 10.6 K (-31.97 %) |
Nov 12 2019 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Buy | M | 10.81 | 180 | 1,946 | 15,640 | 15.5 K to 15.6 K (+1.16 %) |
Nov 12 2019 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Buy | M | 10.34 | 4,820 | 49,839 | 15,460 | 10.6 K to 15.5 K (+45.30 %) |
Nov 12 2019 | PCRX | Pacira BioSciences ... | Scranton Richard | Chief Scientific Of ... | Option Exercise | M | 25.37 | 4,750 | 120,508 | 20,250 | |
Nov 12 2019 | PCRX | Pacira BioSciences ... | Scranton Richard | Chief Scientific Of ... | Option Exercise | M | 10.81 | 14,698 | 158,885 | 0 | |
Nov 12 2019 | PCRX | Pacira BioSciences ... | Scranton Richard | Chief Scientific Of ... | Sell | S | 45.00 | 19,448 | 875,160 | 16,061 | 35.5 K to 16.1 K (-54.77 %) |
Nov 12 2019 | PCRX | Pacira BioSciences ... | Scranton Richard | Chief Scientific Of ... | Buy | M | 25.37 | 4,750 | 120,508 | 35,509 | 30.8 K to 35.5 K (+15.44 %) |
Nov 12 2019 | PCRX | Pacira BioSciences ... | Scranton Richard | Chief Scientific Of ... | Buy | M | 10.81 | 14,698 | 158,885 | 30,759 | 16.1 K to 30.8 K (+91.51 %) |
Oct 04 2019 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Option Exercise | M | 549.00 | 10,000 | 5,490,000 | 26,356 | |
Oct 04 2019 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Option Exercise | M | 1.61 | 7,000 | 11,270 | 29,500 | |
Oct 04 2019 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Buy | M | 5.49 | 10,000 | 54,900 | 187,299 | 177.3 K to 187.3 K (+5.64 %) |
Oct 04 2019 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Buy | M | 1.61 | 7,000 | 11,270 | 177,299 | 170.3 K to 177.3 K (+4.11 %) |
Sep 20 2019 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Option Exercise | M | 5.49 | 6,500 | 35,685 | 36,356 | |
Sep 20 2019 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Option Exercise | M | 1.61 | 7,500 | 12,075 | 36,500 | |
Sep 20 2019 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Buy | M | 5.49 | 6,500 | 35,685 | 170,299 | 163.8 K to 170.3 K (+3.97 %) |
Sep 20 2019 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Buy | M | 1.61 | 7,500 | 12,075 | 163,799 | 156.3 K to 163.8 K (+4.80 %) |
Sep 20 2019 | PCRX | Pacira BioSciences ... | CHRISTIE CHRISTOPHER | Director | Option Exercise | A | 37.16 | 19,919 | 740,190 | 19,919 | |
Aug 16 2019 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Option Exercise | M | 10.81 | 12,849 | 138,898 | 0 | |
Aug 16 2019 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Sell | S | 39.61 | 2,391 | 94,708 | 156,299 | 158.7 K to 156.3 K (-1.51 %) |
Aug 16 2019 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Sell | S | 39.05 | 10,458 | 408,385 | 158,690 | 169.1 K to 158.7 K (-6.18 %) |
Aug 16 2019 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Buy | M | 10.81 | 12,849 | 138,898 | 169,148 | 156.3 K to 169.1 K (+8.22 %) |
Aug 16 2019 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Option Exercise | M | 10.81 | 12,849 | 138,898 | 0 | |
Aug 16 2019 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Sell | S | 39.61 | 2,391 | 94,708 | 156,299 | 158.7 K to 156.3 K (-1.51 %) |
Aug 16 2019 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Sell | S | 39.05 | 10,458 | 408,385 | 158,690 | 169.1 K to 158.7 K (-6.18 %) |
Aug 16 2019 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Buy | M | 10.81 | 12,849 | 138,898 | 169,148 | 156.3 K to 169.1 K (+8.22 %) |
Aug 16 2019 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | Chief Administrativ ... | Sell | S | 39.49 | 6,252 | 246,891 | 19,193 | 25.4 K to 19.2 K (-24.57 %) |
Jul 10 2019 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Sell | S | 43.42 | 700 | 30,394 | 156,299 | 157 K to 156.3 K (-0.45 %) |
Jul 10 2019 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Sell | S | 42.85 | 12,415 | 531,983 | 156,999 | 169.4 K to 157 K (-7.33 %) |
Jul 03 2019 | PCRX | Pacira BioSciences ... | REINHARDT MAX | President | Option Exercise | A | 42.54 | 200,000 | 8,508,000 | 200,000 | |
Jun 13 2019 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Option Exercise | M | 5.49 | 9,000 | 49,410 | 42,856 |